Abstract:Epigenetic gene regulations can be considered as de-novo initiation of abnormal molecular signaling events whose regulation is otherwise required during normal or specific developmental stages of the organisms. Primarily, three different mechanisms have been identified to participate in epigenetic gene regulations which include, DNA methylation, non-coding RNA species (microRNAs [miRNA], and long non-coding RNAs [LNC-RNA]) and histone modifications. These de-novo epigenetic mechanisms have been associated with altered normal cellular functions which eventually facilitate normal cells to transition into an abnormal phenotype. Among the three modes of regulation, RNA species which are usually considered to be less stable, can be speculated to initiate instant alterations in gene expression compared to DNA methylation or histone modifications. However, LNC-RNAs appear to be more stable in the cells than the other RNA species. Moreover, there is increasing literature which clearly suggests that a single specific LNC-RNA can regulate multiple mechanisms and disease phenotypes. With specific focus on cardiovascular diseases, here we attempt to provide UpToDate information on the functional role of miRNAs and LNC-RNAs. Here we discuss the role of these epigenetic mediators in different components of cardiovascular disease which include physiopathological heart development, athersclerosis, retenosis, diabetic hearts, myocardial infarction, ischemia-reperfusion, heart valve disease, aortic aneurysm, osteogenesis, angiogenesis and hypoxia in the heart. While there is abundant literature support that shows the involvement of many LNC-RNAs and miRNAs in cardiovascular diseases, very few RNA species have been identified which regulate epigenetic mechanisms which is the current focus in this article. Understanding the role of these RNA species in regulating epigenetic mechanisms in different cell types causing cardiovascular disease, would advance the field and promote disease prevention approaches that are aimed to target epigenetic mechanisms.

Non-Coding RNAs: Novel Regulators of Macrophage Homeostasis in Ocular Vascular Diseases

Long Non-Coding RNAs: New Players in Ocular Neovascularization

Roles of non-coding RNAs in eye development and diseases.

Emerging Clues of Regulatory Roles of Circular RNAs Through Modulating Oxidative Stress: Focus on Neurological and Vascular Diseases.

Roles of non‐coding <scp>RNAs</scp> in eye development and diseases

Long non-coding RNAs in retinal neovascularization: current research and future directions

The role of long noncoding RNAs in ocular angiogenesis and vascular oculopathy

Circular RNA Expression and the Competitive Endogenous RNA Network in Pathological, Age-Related Macular Degeneration Events: A Cross-Platform Normalization Study

Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration

The roles of long non-coding RNAs in ocular diseases

Roles and mechanisms of long non-coding RNAs in age-related macular degeneration

Circular and long non-coding RNAs and their role in ophthalmologic diseases

Single-cell transcriptomics-based multidisease analysis revealing the molecular dynamics of retinal neurovascular units under inflammatory and hypoxic conditions

Identification of Corneal Neovascularization–Related Long Noncoding RNAs Through Microarray Analysis

Noncoding RNAs in Cataract Formation: Star Molecules Emerge in an Endless Stream.

Non-coding RNAs as Epigenetic Gene Regulators in Cardiovascular Diseases

Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes

Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway

Microarray Expression Profile and Functional Analysis of Circular RNAs in Choroidal Neovascularization

Intravenous Route to Choroidal Neovascularization by Macrophage-Disguised Nanocarriers for Mtor Modulation

Retinal perivascular macrophages regulate immune cell infiltration during neuroinflammation in mouse models of ocular disease